Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by Trennamon Feb 14, 2020 12:45pm
223 Views
Post# 30692327

Overall thoughts...

Overall thoughts...
Just finished listening to the call and I am actually happy the direction the company is going.

Klein and Lee are definitely tightening up the ship and going over the weak points in the company and making the necessary corrections.

Next Q before we get specific details.

Any new CEO coming in will need time to put their stamp on things. A nice button down hard numbers based approach is what I expected and it is what we are now getting.

(Mention of the SAP ERP rollout across the company will take some time to do, again depending on the existing ERP structure in place. This is a company wide procedure and will take months and on going. This is a normal thing for those not familiar with new ERP rollouts.)

There is still a wait for full roll out of vapes (going through the proper UL certification steps right now,) and unfotunately Beverages are going to be delayed for another few months til they are able to scale up and work out the kinks in this new product category.

Going over the FS and MD&A right now and then re-listening to the conf. call and reading the transcript if that is released later.

Note: Klein mentioned that Canopy is switching over to US GAAP and as such Biological assest will no longer get reported as it has been in the past. I think this now falls under Agricultural? Will see in the future Q statements.

Short term pain for long term stable gain is what it is.
I likes it - nice and steady the way to go right now.

Bullboard Posts